세계의 유착 방지제 시장(-2028년) : 제품(재생 셀룰로오스, 히알루론산, PEG), 유형(필름, 겔, 액체), 수술(복부, 심혈관, 부인과, 신경), 최종사용자(병원, 진료소, 외래 수술 센터), 지역별

Adhesion Barrier Market by Product (Regenerated Cellulose, Hyaluronic Acid, PEG), Type (Film, Gel, Liquid), Procedure (Abdominal, Cardiovascular, Gynae, Neurology), End User (Hospitals, Clinics & ASC), Region - Global Forecast to 2028

US $ 4,950 ￦ 6,857,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650 ￦ 9,212,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150 ￦ 11,290,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 13,853,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

유착 방지제 시장 규모는 2023년 약 7억 달러에서 7.4%의 CAGR로 성장하여 2028년에는 9억 달러 규모로 성장할 것으로 예상됩니다.

수술 건수 및 스포츠 관련 부상 증가, 노인 인구 증가, 유착 형성 및 유착 관련 질환에 대한 인식 증가 등의 요인이 이 시장의 성장을 견인할 것으로 예상됩니다.

제품 유형별로는 합성 유착 방지제 부문이 예측 기간 동안 가장 큰 성장을 보일 것으로 예상됩니다. 합성 유착 방지제는 히알루론산, 재생 셀룰로오스, 폴리에틸렌 글리콜, 기타 합성 유착 방지제로 세분화됩니다. 히알루론산 기반 유착 방지제 부문은 생체 적합성과 생체 흡수성 특성으로 인해 시장에서 가장 큰 점유율을 보이고 있습니다.

용도별로는 일반/복부 수술 부문이 2022년 가장 큰 비중을 차지할 것으로 예상됩니다. 일반/복부 수술에서 수술 후 유착 형성의 위험이 높다는 점, 일반/복부 수술 건수가 증가하고 있다는 점, 일반/복부 수술용 유착 방지제 제품이 다수 출시되어 있다는 점 등이 높은 점유율을 보이고 있습니다.

지역별로는 아시아태평양 시장이 예측 기간 동안 가장 큰 성장세를 보일 것으로 예상됩니다. 노령인구의 꾸준한 증가, 감염성 질환에서 만성질환으로의 역학적 변화, 의료관광의 증가 등의 요인으로 인해 이 지역의 성장이 기대됩니다.

세계 유착 방지제 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 기술·특허 동향, 사례 연구, 관련 법규, 시장 규모 추이 및 예측, 각 부문별·지역별·주요 국가별 상세 분석, 경쟁 환경, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 주요 인사이트

제5장 시장 개요

• 시장 역학 : 유착 방지제 시장
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
  • 과제
• 산업 동향
• 규제 분석
• 규제기관, 정부기관, 기타 조직
• 밸류체인 분석
• 공급망 분석
• 생태계 매핑
• Porter's Five Forces 분석
• 특허 분석
• 기술 분석
• 가격 분석
• 주요 회의와 이벤트
• 주요 이해관계자와 구입 기준

제6장 유착 방지제 시장 : 제품별

• 합성 유착 방지제
  • 히알루론산
  • 재생 셀룰로오스
  • 폴리에틸렌 글리콜
  • 기타
• 천연 유착 방지제

제7장 유착 방지제 시장 : 제제별

• 필름 제제
• 겔 제제
• 액체 제제

제8장 유착 방지제 시장 : 용도별

• 일반/복부 수술
• 부인과 수술
• 심혈관 수술
• 정형 수술
• 신경외과 수술
• 재건 수술
• 비뇨기과 수술
• 기타

제9장 유착 방지제 시장 : 최종사용자별

• 병원·진료소
• 외래 수술 센터
• 기타

제10장 유착 방지제 시장 : 지역별

• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제11장 경쟁 상황

• 개요
• 주요 기업의 주요 전략
• 주요 기업의 매출 점유율 분석
• 시장 점유율 분석
• 주요 기업의 기업 평가 매트릭스
• 스타트업/중소기업용 기업 평가 매트릭스
• 경쟁 벤치마킹
• 지역적 발자국
• 경쟁 상황·동향

제12장 기업 개요

• 주요 기업
  • BAXTER INTERNATIONAL INC.
  • JOHNSON & JOHNSON
  • BECTON, DICKINSON AND COMPANY
  • INTEGRA LIFESCIENCES HOLDINGS CORPORATION
  • ANIKA THERAPEUTICS INC.
  • ATRIUM MEDICAL CORPORATION
  • TERUMO CORPORATION
  • FZIOMED, INC.
  • MAST BIOSURGERY
  • INNOCOLL
  • BETATECH MEDICAL
  • CORMATRIX CARDIOVASCULAR, INC.
  • BIOSCOMPASS, INC.
  • W.L. GORE & ASSOCIATES, INC.
  • ALLOSOURCE
• 기타 기업
  • XLYNK SURGICAL
  • LUNA INNOVATIONS
  • ACTAMAX SURGICAL MATERIAL, LLC
  • ARC MEDICAL INC.
  • CG BIO INC.
  • LEADER BIOMEDICAL
  • PLANTTEC MEDICAL GMBH
  • HANGZHOU SINGCLEAN MEDICAL PRODUCTS CO., LTD.
  • SEIKAGAKU CORPORATION
  • GUNZE LIMITED

제13장 부록

ksm

영문 목차

영문목차

The adhesion barriers market is valued at an estimated USD 0.7 billion in 2023 and is projected to reach USD 0.9 baillion by 2028, at a CAGR of 7.4% during the forecast period. The main drivers promoting the development of this market are the rising number of surgeries and sports-related injuries, an increasing elderly population, and the rising awareness of adhesion formation and diseases associated with adhesions.

"The synthetic adhesion barrier market is projected to witness the highest growth in the adhesion barriers market, by type of products, during the forecast period."

Based on products, the adhesion barriers market is further segmented into synthetic and natural adhesion barriers. Synthetic adhesion barriers are further classified into hyaluronic acid, regenerated cellulose, polyethylene glycol, and other synthetic adhesion barriers. the hyaluronic acid based adhesion barriers segment accounted for the largest share of the synthetic adhesion barrier market, owing to their properties of biocompatibility and bioresorbable.

"General/Abdominal Surgeries is the largest application segment of the adhesion barrier market."

In 2022, based on applications, General/Abdominal Surgeries held the largest share of the adhesion barriers market. The large share of this segment can be attributed to factors such as the higher risk of post-surgical adhesion formation in General/Abdominal Surgeries, the growing volume of General/Abdominal Surgeries, and the availability of several commercialized adhesion barrier products for General/Abdominal Surgeries.

"Asia Pacific market to witness the highest growth during the forecast period"

On the basis of region, the adhesion barriers market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Adhesion barrier market is expected to grow in the APAC due to factors such as steadily increasing geriatric population, the epidemiological shift from infectious to chronic diseases, and rising medical tourism. As a result, the APAC is anticipated to grow faster than other regions during the forecast period with the highest CAGR.

A breakdown of the primary participants (supply-side) for the adhesion barrier market referred to for this report is provided below:

a

• By Company Type: Tier 1: 42%, Tier 2: 35%, and Tier 3: 23%
• By Designation: C-level Executives: 28%, Directors: 35%, and Others: 37%
• By Region: North America: 33%, Europe: 24%, Asia Pacific: 18%, Latin America: 10%; Middle East: 10%; Africa: 5%

The prominent players operating in the adhesion barriers market are Baxter International (US), Johnson & Johnson (J&J) (US), and Becton, Dickinson and Company (US), Integra LifeSciences (US), Anika Therapeutics (US), Atrium Medical Corporation (US), FzioMed (US), MAST Biosurgery (Switzerland), Innocoll (Ireland), Betatech Medical (Turkey), CorMatrix Cardiovascular, Inc. (US), Terumo Corporation (Japan), BiosCompass (US), W.L.Gore & Associates (US), GUNZE Limited (Japan), Leader Biomedical (Netherlands), Xlynk Surgical (US), Luna Solutions (US), PlantTec Medical GmbH (Germany), Actamax Surgical Materials, LLC (US), Arc Medical Devices, INC. (US), CG Bio INC. (Korea), Seikagaku Corporation (Japan), Hangzhou Singclean Medical Products Co.,Ltd (China)and Allosource (US).

Research Coverage:

The market study covers the adhesion barrier market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by product, by formulation, by application, by end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall adhesion barrier market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

• Analysis of key drivers (Rising geriatric population, Increase in the volume of surgeries and sports-related injuries, Increasing awareness about the medical implications of adhesions), restraints (Reluctance of surgeons to use adhesion barriers, Product recalls), opportunities (Untapped emerging markets) and challenges (Stringent regulations resulting in limited technological innovations) influencing the growth of the adhesion barrier market
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global adhesion barrier market. The report analyzes this market by type of product , formulation, application, and region.
• Product Enhancement/Innovation: Detailed insights on upcoming trends and service launches in the global adhesion barrier market.
• Market Development: Comprehensive information on the lucrative emerging markets by type of product , formulation, application, and region.
• Market Diversification: Exhaustive information about new products and services, growing geographies, recent developments, and investments in the global adhesion barrier market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product and service offerings, and capabilities of leading players in the global adhesion barrier market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 PRODUCT
  • 1.2.2 FORMULATION
• 1.3 INCLUSIONS AND EXCLUSIONS
  • 1.3.1 MARKETS COVERED
  • 1.3.2 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
  • TABLE 1 STANDARD CURRENCY CONVERSION RATES
• 1.5 STAKEHOLDERS
• 1.6 SUMMARY OF CHANGES
  • 1.6.1 RECESSION IMPACT: ADHESION BARRIER MARKET

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • FIGURE 1 RESEARCH DESIGN
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
  • FIGURE 2 PRIMARY SOURCES
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Key industry insights
  • FIGURE 3 PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY-SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND-SIDE): BY END USER, DESIGNATION, AND REGION
• 2.2 MARKET SIZE ESTIMATION
  • FIGURE 6 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION: BAXTER INTERNATIONAL
  • FIGURE 8 SUPPLY-SIDE ANALYSIS: ADHESION BARRIER MARKET
  • FIGURE 9 TOP-DOWN APPROACH
  • FIGURE 10 BOTTOM-UP APPROACH
  • FIGURE 11 US: ORTHOPEDIC SURGERIES APPROACH
  • FIGURE 12 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FOR ADHESION BARRIER MARKET (2023-2028)
  • FIGURE 13 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
• 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • FIGURE 14 DATA TRIANGULATION METHODOLOGY
• 2.4 MARKET SHARE ESTIMATION
• 2.5 STUDY ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
  • 2.6.1 SCOPE-RELATED LIMITATIONS
  • 2.6.2 METHODOLOGY-RELATED LIMITATIONS
• 2.7 RISK ASSESSMENT
  • TABLE 2 RISK ASSESSMENT: ADHESION BARRIER MARKET
• 2.8 IMPACT OF RECESSION ON ADHESION BARRIER MARKET

3 EXECUTIVE SUMMARY

• FIGURE 15 ADHESION BARRIER MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
• FIGURE 16 ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2023 VS. 2028 (USD MILLION)
• FIGURE 17 ADHESION BARRIER MARKET, BY FORMULATION, 2023 VS. 2028 (USD MILLION)
• FIGURE 18 ADHESION BARRIER MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
• FIGURE 19 ADHESION BARRIER MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
• FIGURE 20 GEOGRAPHICAL SNAPSHOT OF ADHESION BARRIER MARKET

4 PREMIUM INSIGHTS

• 4.1 ADHESION BARRIER MARKET OVERVIEW
  • FIGURE 21 INCREASING VOLUME OF SURGERIES RISING GERIATRIC POPULATION TO DRIVE MARKET
• 4.2 ASIA PACIFIC: ADHESION BARRIER MARKET, BY PRODUCT AND COUNTRY (2022)
  • FIGURE 22 SYNTHETIC BARRIERS ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC ADHESION BARRIER MARKET IN 2022
• 4.3 ADHESION BARRIER MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
  • FIGURE 23 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
• 4.4 REGIONAL MIX: ADHESION BARRIER MARKET (2023-2028)
  • FIGURE 24 NORTH AMERICA TO DOMINATE ADHESION BARRIER MARKET IN 2028
• 4.5 ADHESION BARRIER MARKET: EMERGING VS. DEVELOPED ECONOMIES
  • FIGURE 25 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS: ADHESION BARRIER MARKET
  • 5.2.1 DRIVERS
    • 5.2.1.1 Rapid growth in geriatric population globally
  • TABLE 3 GROWTH RATE IN GERIATRIC POPULATION, BY REGION, 2020-2050
  • TABLE 4 LIST OF COMMON SPECIALTIES AND PROCEDURES IN OLDER ADULTS
    • 5.2.1.2 Increase in volume of surgeries and sports-related injuries
  • TABLE 5 US: PERCENTAGE INCREASE IN NUMBER OF SURGICAL PROCEDURES PERFORMED (2010 VS. 2020)
    • 5.2.1.3 Increasing awareness about medical implications of adhesions
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Reluctance of surgeons to use adhesion barriers
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Untapped markets in emerging economies
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Stringent regulations and limited technological innovations
• 5.3 INDUSTRY TRENDS
  • 5.3.1 RISING FOCUS ON GEL FORM OF ADHESION BARRIERS FOR SURGERIES
  • TABLE 6 AVERAGE ADHESION FORMATION RATE IN LAPAROSCOPIC SURGERIES
• 5.4 REGULATORY ANALYSIS
  • 5.4.1 NORTH AMERICA
    • 5.4.1.1 US
  • TABLE 7 CLASSIFICATION OF MEDICAL DEVICES BY US FDA
  • FIGURE 26 PREMARKET NOTIFICATION: 510(K) APPROVAL FOR MEDICAL DEVICES
    • 5.4.1.2 Canada
  • FIGURE 27 APPROVAL PROCESS FOR CLASS III MEDICAL DEVICES IN CANADA
  • 5.4.2 EUROPE
  • FIGURE 28 CE APPROVAL PROCESS IN EUROPE FOR BIOSURGERY PRODUCTS
  • 5.4.3 ASIA PACIFIC
    • 5.4.3.1 Japan
  • TABLE 8 CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODY IN JAPAN
    • 5.4.3.2 China
  • TABLE 9 NMPA MEDICAL DEVICE CLASSIFICATION
    • 5.4.3.3 India
• 5.5 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.6 VALUE CHAIN ANALYSIS
  • FIGURE 29 VALUE CHAIN ANALYSIS: MAXIMUM VALUE ADDED DURING COMPONENT AND PRODUCT MANUFACTURING PHASE
• 5.7 SUPPLY CHAIN ANALYSIS
  • FIGURE 30 ADHESION BARRIER MARKET: SUPPLY CHAIN ANALYSIS
• 5.8 ECOSYSTEM MAPPING
  • FIGURE 31 ADHESION BARRIER MARKET: ECOSYSTEM MAPPING
• 5.9 PORTER'S FIVE FORCES ANALYSIS
  • TABLE 13 PORTER'S FIVE FORCES ANALYSIS
  • 5.9.1 THREAT OF NEW ENTRANTS
  • 5.9.2 THREAT OF SUBSTITUTES
  • 5.9.3 BARGAINING POWER OF SUPPLIERS
  • 5.9.4 BARGAINING POWER OF BUYERS
  • 5.9.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.10 PATENT ANALYSIS
  • 5.10.1 PATENT PUBLICATION TRENDS FOR ADHESION BARRIERS
  • FIGURE 32 ADHESION BARRIER MARKET: GLOBAL PATENT PUBLICATION TRENDS (2015-2023)
  • 5.10.2 ADHESION BARRIER MARKET: TOP APPLICANTS
  • FIGURE 33 TOP APPLICANTS FOR ADHESION BARRIER PATENTS (2015-2023)
  • 5.10.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS
  • FIGURE 34 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR ADHESION BARRIER PATENTS (2015-2023)
• 5.11 TECHNOLOGY ANALYSIS
  • TABLE 14 ANTI-ADHESION BARRIERS AS SUBJECT OF RECENT RESEARCH
• 5.12 PRICING ANALYSIS
  • TABLE 15 AVERAGE SELLING PRICE OF ADHESION BARRIER PRODUCTS OFFERED BY KEY PLAYERS
• 5.13 KEY CONFERENCES AND EVENTS (2023-2025)
• 5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • FIGURE 35 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR ADHESION BARRIER PRODUCTS
  • TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR ADHESION BARRIER PRODUCTS
  • 5.14.2 BUYING CRITERIA
  • FIGURE 36 KEY BUYING CRITERIA FOR ADHESION BARRIER PRODUCTS
  • TABLE 17 KEY BUYING CRITERIA FOR ADHESION BARRIER PRODUCTS

6 ADHESION BARRIER MARKET, BY PRODUCT

• 6.1 INTRODUCTION
  • TABLE 18 ADHESION BARRIER MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
• 6.2 SYNTHETIC ADHESION BARRIERS
  • TABLE 19 KEY BRANDS OF SYNTHETIC ADHESION BARRIERS
  • TABLE 20 ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 21 ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.2.1 HYALURONIC ACID
    • 6.2.1.1 Greater biocompatibility and higher bioresorbability to drive segment
  • TABLE 22 HYALURONIC ACID MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.2.2 REGENERATED CELLULOSE
    • 6.2.2.1 Non-reactive and bacteriostatic nature of regenerated cellulose to drive use in gynecological surgeries
  • TABLE 23 REGENERATED CELLULOSE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.2.3 POLYETHYLENE GLYCOL
    • 6.2.3.1 Ability to decrease post-surgical adhesions after abdominal and peritoneal surgeries to drive segment
  • TABLE 24 POLYETHYLENE GLYCOL MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.2.4 OTHER SYNTHETIC ADHESION BARRIERS
  • TABLE 25 OTHER SYNTHETIC ADHESION BARRIERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
• 6.3 NATURAL ADHESION BARRIERS
  • 6.3.1 TIME-CONSUMING AND COMPLEX APPLICATIONS DURING SURGERIES TO LIMIT MARKET
  • TABLE 26 LIST OF NATURAL ADHESION BARRIERS AVAILABLE
  • TABLE 27 ADHESION BARRIER MARKET FOR NATURAL ADHESION BARRIERS, BY COUNTRY, 2021-2028 (USD MILLION)

7 ADHESION BARRIER MARKET, BY FORMULATION

• 7.1 INTRODUCTION
  • TABLE 28 ADOPTION OF DIFFERENT ADHESION BARRIER FORMULATIONS IN SURGERIES
  • TABLE 29 ADHESION BARRIER MARKET, BY FORMULATION, 2021-2028 (USD MILLION)
• 7.2 FILM FORMULATIONS
  • 7.2.1 FILM FORMULATIONS DOMINATED ADHESION BARRIER MARKET IN 2022
  • TABLE 30 INDICATIVE LIST OF COMMERCIALLY AVAILABLE ADHESION BARRIERS WITH FILM FORMULATIONS
  • TABLE 31 ADHESION BARRIER MARKET FOR FILM FORMULATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
• 7.3 GEL FORMULATIONS
  • 7.3.1 HIGHER PREFERENCE FOR GEL-BASED FORMULATIONS OVER FILM-BASED BARRIERS TO DRIVE MARKET
  • TABLE 32 INDICATIVE LIST OF COMMERCIALLY AVAILABLE ADHESION BARRIERS WITH GEL FORMULATIONS
  • TABLE 33 ADHESION BARRIER MARKET FOR GEL FORMULATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
• 7.4 LIQUID FORMULATIONS
  • 7.4.1 LIQUID FORMULATIONS TO BE WIDELY USED IN GYNECOLOGICAL, PELVIC, AND ABDOMINAL SURGERIES
  • TABLE 34 INDICATIVE LIST OF COMMERCIALLY AVAILABLE ADHESION BARRIERS WITH LIQUID FORMULATIONS
  • TABLE 35 ADHESION BARRIER MARKET FOR LIQUID FORMULATIONS, BY COUNTRY, 2021-2028 (USD MILLION)

8 ADHESION BARRIER MARKET, BY APPLICATION

• 8.1 INTRODUCTION
  • TABLE 36 ADHESION BARRIER MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
• 8.2 GENERAL/ABDOMINAL SURGERIES
  • 8.2.1 INCREASING FORMATION OF POST-OPERATIVE ADHESIONS AND RISING COMPLICATIONS AMONG PATIENTS TO DRIVE MARKET
  • TABLE 37 ADHESION BARRIER MARKET FOR GENERAL/ABDOMINAL SURGERIES, BY COUNTRY, 2021-2028 (USD MILLION)
• 8.3 GYNECOLOGICAL SURGERIES
  • 8.3.1 RISING INCIDENCE OF PELVIC AND UTERINE CANCER AND INCREASING NUMBER OF C-SECTIONS TO DRIVE MARKET
  • TABLE 38 PREVALENCE OF INTRAUTERINE ADHESIONS ACROSS DIFFERENT GYNECOLOGICAL PROCEDURES (IN %)
  • TABLE 39 COUNTRIES WITH HIGHEST C-SECTION RATES (2022)
  • TABLE 40 ADHESION BARRIER MARKET FOR GYNECOLOGICAL SURGERIES, BY COUNTRY, 2021-2028 (USD MILLION)
• 8.4 CARDIOVASCULAR SURGERIES
  • 8.4.1 INCREASING NUMBER OF POST-OPERATIVE COMPLICATIONS TO DRIVE MARKET
  • TABLE 41 INDICATIVE LIST OF COMMERCIALLY AVAILABLE ADHESION BARRIERS FOR CARDIOVASCULAR SURGICAL APPLICATIONS
  • TABLE 42 ADHESION BARRIER MARKET FOR CARDIOVASCULAR SURGERIES, BY COUNTRY, 2021-2028 (USD MILLION)
• 8.5 ORTHOPEDIC SURGERIES
  • 8.5.1 GROWING NUMBER OF SPORT-RELATED INJURIES TO DRIVE MARKET
  • TABLE 43 ADHESION BARRIER MARKET FOR ORTHOPEDIC SURGERIES, BY COUNTRY, 2021-2028 (USD MILLION)
• 8.6 NEUROLOGICAL SURGERIES
  • 8.6.1 GROWING CONCERNS ABOUT PHYSICAL PAIN AND IMPAIRMENT AFTER NEUROLOGICAL SURGERIES TO DRIVE MARKET
  • TABLE 44 ADHESION BARRIER MARKET FOR NEUROLOGICAL SURGERIES, BY COUNTRY, 2021-2028 (USD MILLION)
• 8.7 RECONSTRUCTIVE SURGERIES
  • 8.7.1 HIGHER INSURANCE COVERAGE FOR COSMETIC SURGERIES TO DRIVE MARKET
  • TABLE 45 ADHESION BARRIER MARKET FOR RECONSTRUCTIVE SURGERIES, BY COUNTRY, 2021-2028 (USD MILLION)
• 8.8 UROLOGICAL SURGERIES
  • 8.8.1 GROWING INCIDENCE OF POST-OPERATIVE ADHESION FORMATION TO DRIVE MARKET
  • TABLE 46 ADHESION BARRIER MARKET FOR UROLOGICAL SURGERIES, BY COUNTRY, 2021-2028 (USD MILLION)
• 8.9 OTHER SURGERIES
  • TABLE 47 ADHESION BARRIER MARKET FOR OTHER SURGERIES, BY COUNTRY, 2021-2028 (USD MILLION)

9 ADHESION BARRIER MARKET, BY END USER

• 9.1 INTRODUCTION
  • TABLE 48 ADHESION BARRIER MARKET, BY END USER, 2021-2028 (USD MILLION)
• 9.2 HOSPITALS AND CLINICS
  • 9.2.1 GROWING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES AND RISING ADOPTION OF SAFETY MEASURES TO DRIVE MARKET
  • TABLE 49 ADHESION BARRIER MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021-2028 (USD MILLION)
• 9.3 AMBULATORY SURGICAL CENTERS
  • 9.3.1 INCREASING NUMBER OF OUTPATIENT VISITS AND FAVORABLE REIMBURSEMENT POLICIES TO DRIVE MARKET
  • TABLE 50 ADHESION BARRIER MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
• 9.4 OTHER END USERS
  • TABLE 51 ADHESION BARRIER MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)

10 ADHESION BARRIER MARKET, BY REGION

• 10.1 INTRODUCTION
  • TABLE 52 ADHESION BARRIER MARKET, BY REGION, 2021-2028 (USD MILLION)
• 10.2 NORTH AMERICA
  • TABLE 53 US: ARTHROPLASTY PROCEDURAL VOLUME, BY YEAR (N = 1,787,914)
  • 10.2.1 NORTH AMERICA: RECESSION IMPACT
  • TABLE 54 NORTH AMERICA: HEALTHCARE EXPENDITURE, BY COUNTRY (USD BILLION)
  • FIGURE 37 NORTH AMERICA: ADHESION BARRIER MARKET SNAPSHOT
  • TABLE 55 NORTH AMERICA: ADHESION BARRIER MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 56 NORTH AMERICA: ADHESION BARRIER MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 57 NORTH AMERICA: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 58 NORTH AMERICA: ADHESION BARRIER MARKET, BY FORMULATION, 2021-2028 (USD MILLION)
  • TABLE 59 NORTH AMERICA: ADHESION BARRIER MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 60 NORTH AMERICA: ADHESION BARRIER MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.2.2 US
    • 10.2.2.1 US dominated North American adhesion barrier market in 2022
  • FIGURE 38 GERIATRIC POPULATION IN US (65 YEARS AND ABOVE IN MILLION)
  • TABLE 61 US: KEY MACROINDICATORS
  • TABLE 62 US: ADHESION BARRIER MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 63 US: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 64 US: ADHESION BARRIER MARKET, BY FORMULATION, 2021-2028 (USD MILLION)
  • TABLE 65 US: ADHESION BARRIER MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 66 US: ADHESION BARRIER MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.2.3 CANADA
    • 10.2.3.1 Increasing number of C-section surgeries to drive market
  • TABLE 67 CANADA: KEY MACROINDICATORS
  • TABLE 68 CANADA: ADHESION BARRIER MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 69 CANADA: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 70 CANADA: ADHESION BARRIER MARKET, BY FORMULATION, 2021-2028 (USD MILLION)
  • TABLE 71 CANADA: ADHESION BARRIER MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 72 CANADA: ADHESION BARRIER MARKET, BY END USER, 2021-2028 (USD MILLION)
• 10.3 EUROPE
  • TABLE 73 EUROPEAN COUNTRIES WITH HIGHEST C-SECTION RATE (2021)
  • 10.3.1 EUROPE: RECESSION IMPACT
  • TABLE 74 EUROPE: ADHESION BARRIER MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 75 EUROPE: ADHESION BARRIER MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 76 EUROPE: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 77 EUROPE: ADHESION BARRIER MARKET, BY FORMULATION, 2021-2028 (USD MILLION)
  • TABLE 78 EUROPE: ADHESION BARRIER MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 79 EUROPE: ADHESION BARRIER MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.3.2 GERMANY
    • 10.3.2.1 Germany accounted for largest share of European adhesion barrier market in 2022
  • TABLE 80 GERMANY: KEY MACROINDICATORS
  • TABLE 81 GERMANY: ADHESION BARRIER MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 82 GERMANY: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 83 GERMANY: ADHESION BARRIER MARKET, BY FORMULATION, 2021-2028 (USD MILLION)
  • TABLE 84 GERMANY: ADHESION BARRIER MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 85 GERMANY: ADHESION BARRIER MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.3.3 FRANCE
    • 10.3.3.1 Rising number of advanced orthopedic surgeries to drive market
  • TABLE 86 FRANCE: KEY MACROINDICATORS
  • TABLE 87 FRANCE: ADHESION BARRIER MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 88 FRANCE: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 89 FRANCE: ADHESION BARRIER MARKET, BY FORMULATION, 2021-2028 (USD MILLION)
  • TABLE 90 FRANCE: ADHESION BARRIER MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 91 FRANCE: ADHESION BARRIER MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.3.4 UK
    • 10.3.4.1 Rising number of cardiovascular, gynecological, and orthopedic surgeries to drive market
  • TABLE 92 UK: PERCENTAGE SHARE OF AGING POPULATION (2019-2036)
  • TABLE 93 UK: KEY MACROINDICATORS
  • TABLE 94 UK: ADHESION BARRIER MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 95 UK: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 96 UK: ADHESION BARRIER MARKET, BY FORMULATION, 2021-2028 (USD MILLION)
  • TABLE 97 UK: ADHESION BARRIER MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 98 UK: ADHESION BARRIER MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.3.5 ITALY
    • 10.3.5.1 Rising geriatric population and increasing prevalence of chronic diseases to drive market
  • TABLE 99 ITALY: KEY MACROINDICATORS
  • TABLE 100 ITALY: ADHESION BARRIER MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 101 ITALY: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 102 ITALY: ADHESION BARRIER MARKET, BY FORMULATION, 2021-2028 (USD MILLION)
  • TABLE 103 ITALY: ADHESION BARRIER MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 104 ITALY: ADHESION BARRIER MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.3.6 SPAIN
    • 10.3.6.1 High cost of surgical procedures to limit market
  • TABLE 105 SPAIN: KEY MACROINDICATORS
  • TABLE 106 SPAIN: ADHESION BARRIER MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 107 SPAIN: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 108 SPAIN: ADHESION BARRIER MARKET, BY FORMULATION, 2021-2028 (USD MILLION)
  • TABLE 109 SPAIN: ADHESION BARRIER MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 110 SPAIN: ADHESION BARRIER MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.3.7 REST OF EUROPE
  • TABLE 111 REST OF EUROPE: ADHESION BARRIER MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 112 REST OF EUROPE: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 113 REST OF EUROPE: ADHESION BARRIER MARKET, BY FORMULATION, 2021-2028 (USD MILLION)
  • TABLE 114 REST OF EUROPE: ADHESION BARRIER MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 115 REST OF EUROPE: ADHESION BARRIER MARKET, BY END USER, 2021-2028 (USD MILLION)
• 10.4 ASIA PACIFIC
  • FIGURE 39 ASIA PACIFIC: ADHESION BARRIER MARKET SNAPSHOT
  • 10.4.1 ASIA PACIFIC: RECESSION IMPACT
  • TABLE 116 ASIA PACIFIC: ADHESION BARRIER MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 117 ASIA PACIFIC: ADHESION BARRIER MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 118 ASIA PACIFIC: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 119 ASIA PACIFIC: ADHESION BARRIER MARKET, BY FORMULATION, 2021-2028 (USD MILLION)
  • TABLE 120 ASIA PACIFIC: ADHESION BARRIER MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 121 ASIA PACIFIC: ADHESION BARRIER MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.4.2 JAPAN
    • 10.4.2.1 Rising geriatric population and increasing number of surgical procedures performed to drive market
  • TABLE 122 JAPAN: KEY MACROINDICATORS
  • TABLE 123 JAPAN: ADHESION BARRIER MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 124 JAPAN: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 125 JAPAN: ADHESION BARRIER MARKET, BY FORMULATION, 2021-2028 (USD MILLION)
  • TABLE 126 JAPAN: ADHESION BARRIER MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 127 JAPAN: ADHESION BARRIER MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.4.3 CHINA
    • 10.4.3.1 Rapid economic growth and increasing disposable income of middle-class population to drive market
  • TABLE 128 CHINA: KEY MACROINDICATORS
  • TABLE 129 CHINA: ADHESION BARRIER MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 130 CHINA: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 131 CHINA: ADHESION BARRIER MARKET, BY FORMULATION, 2021-2028 (USD MILLION)
  • TABLE 132 CHINA: ADHESION BARRIER MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 133 CHINA: ADHESION BARRIER MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.4.4 INDIA
    • 10.4.4.1 Rising focus of multinational companies and improving urban healthcare infrastructure to drive market
  • TABLE 134 INDIA: KEY MACROINDICATORS
  • TABLE 135 INDIA: ADHESION BARRIER MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 136 INDIA: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 137 INDIA: ADHESION BARRIER MARKET, BY FORMULATION, 2021-2028 (USD MILLION)
  • TABLE 138 INDIA: ADHESION BARRIER MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 139 INDIA: ADHESION BARRIER MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.4.5 AUSTRALIA
    • 10.4.5.1 Growing government awareness campaigns and rising funding and grants for medical research to drive market
  • TABLE 140 AUSTRALIA: KEY MACROINDICATORS
  • TABLE 141 AUSTRALIA: ADHESION BARRIER MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 142 AUSTRALIA: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 143 AUSTRALIA: ADHESION BARRIER MARKET, BY FORMULATION, 2021-2028 (USD MILLION)
  • TABLE 144 AUSTRALIA: ADHESION BARRIER MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 145 AUSTRALIA: ADHESION BARRIER MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.4.6 SOUTH KOREA
    • 10.4.6.1 Growing geriatric population and increasing disposable incomes to drive market
  • TABLE 146 SOUTH KOREA: KEY MACROINDICATORS
  • TABLE 147 SOUTH KOREA: ADHESION BARRIER MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 148 SOUTH KOREA: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 149 SOUTH KOREA: ADHESION BARRIER MARKET, BY FORMULATION, 2021-2028 (USD MILLION)
  • TABLE 150 SOUTH KOREA: ADHESION BARRIER MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 151 SOUTH KOREA: ADHESION BARRIER MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.4.7 REST OF ASIA PACIFIC
  • TABLE 152 NEW ZEALAND: REGISTERED JOINT ARTHROPLASTIES CONDUCTED FROM 2015-2021
  • TABLE 153 REST OF ASIA PACIFIC: ADHESION BARRIER MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 154 REST OF ASIA PACIFIC: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 155 REST OF ASIA PACIFIC: ADHESION BARRIER MARKET, BY FORMULATION, 2021-2028 (USD MILLION)
  • TABLE 156 REST OF ASIA PACIFIC: ADHESION BARRIER MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 157 REST OF ASIA PACIFIC: ADHESION BARRIER MARKET, BY END USER, 2021-2028 (USD MILLION)
• 10.5 LATIN AMERICA
  • 10.5.1 LATIN AMERICA: RECESSION IMPACT
  • TABLE 158 LATIN AMERICA: ADHESION BARRIER MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 159 LATIN AMERICA: ADHESION BARRIER MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 160 LATIN AMERICA: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 161 LATIN AMERICA: ADHESION BARRIER MARKET, BY FORMULATION, 2021-2028 (USD MILLION)
  • TABLE 162 LATIN AMERICA: ADHESION BARRIER MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 163 LATIN AMERICA: ADHESION BARRIER MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.5.2 BRAZIL
    • 10.5.2.1 Brazil to command largest market share for adhesion barriers in Latin America
  • TABLE 164 BRAZIL: KEY MACROINDICATORS
  • TABLE 165 BRAZIL: ADHESION BARRIER MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 166 BRAZIL: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 167 BRAZIL: ADHESION BARRIER MARKET, BY FORMULATION, 2021-2028 (USD MILLION)
  • TABLE 168 BRAZIL: ADHESION BARRIER MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 169 BRAZIL: ADHESION BARRIER MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.5.3 MEXICO
    • 10.5.3.1 Rising burden of chronic diseases and well-organized healthcare system to drive market
  • TABLE 170 MEXICO: KEY MACROINDICATORS
  • TABLE 171 MEXICO: ADHESION BARRIER MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 172 MEXICO: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 173 MEXICO: ADHESION BARRIER MARKET, BY FORMULATION, 2021-2028 (USD MILLION)
  • TABLE 174 MEXICO: ADHESION BARRIER MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 175 MEXICO: ADHESION BARRIER MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.5.4 REST OF LATIN AMERICA
  • TABLE 176 REST OF LATIN AMERICA: ADHESION BARRIER MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 177 REST OF LATIN AMERICA: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 178 REST OF LATIN AMERICA: ADHESION BARRIER MARKET, BY FORMULATION, 2021-2028 (USD MILLION)
  • TABLE 179 REST OF LATIN AMERICA: ADHESION BARRIER MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 180 REST OF LATIN AMERICA: ADHESION BARRIER MARKET, BY END USER, 2021-2028 (USD MILLION)
• 10.6 MIDDLE EAST & AFRICA
  • 10.6.1 INCREASING NUMBER OF GYNECOLOGICAL AND GENERAL SURGERIES TO DRIVE MARKET
  • 10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
  • TABLE 181 MIDDLE EAST & AFRICA: ADHESION BARRIER MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 182 MIDDLE EAST & AFRICA: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 183 MIDDLE EAST & AFRICA: ADHESION BARRIER MARKET, BY FORMULATION, 2021-2028 (USD MILLION)
  • TABLE 184 MIDDLE EAST & AFRICA: ADHESION BARRIER MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 185 MIDDLE EAST & AFRICA: ADHESION BARRIER MARKET, BY END USER, 2021-2028 (USD MILLION)

11 COMPETITIVE LANDSCAPE

• 11.1 OVERVIEW
• 11.2 KEY STRATEGIES ADOPTED BY MAJOR PLAYERS IN ADHESION BARRIER MARKET (JANUARY 2020- JULY 2023)
• 11.3 REVENUE SHARE ANALYSIS OF KEY PLAYERS
  • FIGURE 40 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN ADHESION BARRIER MARKET (2018-2022)
• 11.4 MARKET SHARE ANALYSIS
  • FIGURE 41 ADHESION BARRIER MARKET SHARE, BY KEY PLAYER, 2022
• 11.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS
  • 11.5.1 STARS
  • 11.5.2 EMERGING LEADERS
  • 11.5.3 PERVASIVE PLAYERS
  • 11.5.4 PARTICIPANTS
  • FIGURE 42 ADHESION BARRIER MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022
• 11.6 COMPANY EVALUATION MATRIX FOR START-UPS/SMES
  • 11.6.1 PROGRESSIVE COMPANIES
  • 11.6.2 DYNAMIC COMPANIES
  • 11.6.3 STARTING BLOCKS
  • 11.6.4 RESPONSIVE COMPANIES
  • FIGURE 43 ADHESION BARRIER MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022)
• 11.7 COMPETITIVE BENCHMARKING
  • TABLE 186 PRODUCT PORTFOLIO ANALYSIS: ADHESION BARRIER MARKET
  • TABLE 187 FORMULATION PORTFOLIO ANALYSIS: ADHESION BARRIER MARKET
  • TABLE 188 APPLICATION PORTFOLIO ANALYSIS: ADHESION BARRIER MARKET
  • TABLE 189 END USER PORTFOLIO ANALYSIS: ADHESION BARRIER MARKET
  • TABLE 190 OVERALL PORTFOLIO ANALYSIS: ADHESION BARRIER MARKET
• 11.8 COMPANY GEOGRAPHICAL FOOTPRINT
  • TABLE 191 REGIONAL REVENUE MIX: ADHESION BARRIER MARKET
• 11.9 COMPETITIVE SITUATION AND TRENDS
  • 11.9.1 KEY PRODUCT LAUNCHES AND APPROVALS
  • TABLE 192 KEY PRODUCT LAUNCHES AND APPROVALS
  • 11.9.2 KEY ACQUISITIONS

12 COMPANY PROFILES

• 12.1 KEY PLAYERS
• (Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)**
• 12.1.1 BAXTER INTERNATIONAL INC.
• TABLE 193 BAXTER INTERNATIONAL INC: COMPANY OVERVIEW
• FIGURE 44 BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT (2022)
• 12.1.2 JOHNSON & JOHNSON
• TABLE 194 JOHNSON & JOHNSON: COMPANY OVERVIEW
• FIGURE 45 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2022)
• 12.1.3 BECTON, DICKINSON AND COMPANY
• TABLE 195 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
• FIGURE 46 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
• 12.1.4 INTEGRA LIFESCIENCES HOLDINGS CORPORATION
• TABLE 196 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY OVERVIEW
• FIGURE 47 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT (2022)
• 12.1.5 ANIKA THERAPEUTICS INC.
• TABLE 197 ANIKA THERAPEUTICS INC.: COMPANY OVERVIEW
• FIGURE 48 ANIKA THERAPEUTICS INC.: COMPANY SNAPSHOT (2022)
• 12.1.6 ATRIUM MEDICAL CORPORATION
• TABLE 198 ATRIUM MEDICAL CORPORATION: COMPANY OVERVIEW
• FIGURE 49 ATRIUM MEDICAL CORPORATION: COMPANY SNAPSHOT (2022)
• 12.1.7 TERUMO CORPORATION
• TABLE 199 TERUMO CORPORATION: COMPANY OVERVIEW
• FIGURE 50 TERUMO CORPORATION: COMPANY SNAPSHOT (2022)
• 12.1.8 FZIOMED, INC.
• TABLE 200 FZIOMED, INC.: COMPANY OVERVIEW
• 12.1.9 MAST BIOSURGERY
• TABLE 201 MAST BIOSURGERY: COMPANY OVERVIEW
• 12.1.10 INNOCOLL
• TABLE 202 INNOCOLL: COMPANY OVERVIEW
• 12.1.11 BETATECH MEDICAL
• TABLE 203 BETATECH MEDICAL: COMPANY OVERVIEW
• 12.1.12 CORMATRIX CARDIOVASCULAR, INC.
• TABLE 204 CORMATRIX CARDIOVASCULAR, INC.: COMPANY OVERVIEW
• 12.1.13 BIOSCOMPASS, INC.
• TABLE 205 BIOSCOMPASS, INC.: COMPANY OVERVIEW
• 12.1.14 W.L. GORE & ASSOCIATES, INC.
• TABLE 206 W. L. GORE & ASSOCIATES, INC.: COMPANY OVERVIEW
• 12.1.15 ALLOSOURCE
• TABLE 207 ALLOSOURCE: COMPANY OVERVIEW
• *Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
• 12.2 OTHER PLAYERS (ADHESION BARRIER PRODUCTS UNDER DEVELOPMENT)
  • 12.2.1 XLYNK SURGICAL
  • 12.2.2 LUNA INNOVATIONS
  • 12.2.3 ACTAMAX SURGICAL MATERIAL, LLC
  • 12.2.4 ARC MEDICAL INC.
  • 12.2.5 CG BIO INC.
  • 12.2.6 LEADER BIOMEDICAL
  • 12.2.7 PLANTTEC MEDICAL GMBH
  • 12.2.8 HANGZHOU SINGCLEAN MEDICAL PRODUCTS CO., LTD.
  • 12.2.9 SEIKAGAKU CORPORATION
  • 12.2.10 GUNZE LIMITED

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 CUSTOMIZATION OPTIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS

관련자료